Pet health trackers: which startup is ahead?
In our Pet Tech market deck, you will find everything you need to understand the market
SUMMARY
Tractive is clearly ahead in pet health trackers today. Fi is the strongest independent consumer challenger, while PetPace leads the medical side of the market.
Tractive's lead is built on a real subscription business, not just product reviews or brand recognition. More than 1.4 million active users, over €100 million in recurring subscription revenue and coverage across more than 175 countries put it in a different commercial tier.
Fi is not close to matching that proven scale yet, but it has built some of the category's best hardware. Its long-battery-life collars and new satellite-enabled Ultra make it the most credible rival for owners who care first about escape prevention and remote tracking.
The market is splitting into two races. Tractive and Fi compete for everyday safety and wellness, while PetPace, Invoxia and Maven are trying to make the collar useful for medical monitoring.
PetPace has the deepest health product. Its vital-sign measurements, veterinarian dashboard and clinical research make it more useful for sick, elderly or recovering animals than a normal consumer GPS tracker.
Invoxia may have the strongest technical position among the smaller companies. Its cardiac sensing and long-term study of 703 dogs give it a dataset that is difficult to reproduce with standard GPS and activity hardware.
Maven is smaller, but it has found a sensible middle ground. Peer-reviewed respiratory monitoring, personalized baselines and one subscription covering several pets make it a credible health-first challenger without the cost of a full clinical platform.
Connected hardware economics matter more than they first appear. Tractive's recurring revenue can support cellular fees, replacement devices, software development and customer service at a scale that smaller rivals still have to fund carefully.
Life360 is the biggest outside threat because it already has distribution. Its pet tracker is medically basic, but placing pet location inside an app used by more than 97 million people could pressure GPS-focused brands quickly.
The ranking depends on what pet wearables become. If owners mainly want escape alerts and location, Tractive and Fi should stay in front; if veterinary care and insurance begin using continuous pet data routinely, PetPace, Invoxia and Maven become much more valuable.
For now, the order is clear: Tractive first, Fi second, PetPace third, Invoxia fourth, Maven fifth, Petcube sixth and FitBark seventh.
Which pet health tracker startups actually belong in the race?
The real pet health tracker race currently has seven credible companies: Tractive, Fi, Invoxia, PetPace, Maven Pet, Petcube and FitBark.
We include companies that sell an active wearable and track at least one health or behavioral metric. That covers broad GPS products that monitor activity and sleep, as well as health-first collars measuring heart rate, breathing or temperature.
The companies are still solving different problems. Tractive and Fi began with location and safety, then added health features. PetPace and Maven started with health monitoring. Invoxia sits between the two, combining GPS with unusually advanced cardiac measurements.
Tractive remains essential to the comparison even though Bending Spoons has acquired it. It may no longer be independent, but it still sets the benchmark every startup has to beat. Whistle is excluded because Tractive acquired the business and closed the separate Whistle platform.
We also exclude Halo and SpotOn because containment and training remain their main functions. Apple AirTags and similar Bluetooth tags can help locate an animal nearby, but they do not monitor health. Life360 appears later as an outside threat because it is an established consumer platform entering pet tracking, rather than a pet health startup.
Funding figures need some caution. Fi has raised slightly more disclosed venture funding than Tractive raised before its acquisition. Invoxia and PetPace have less complete public records, so their totals should be read as approximate rather than exact.
| Startup | What it currently does | Disclosed cumulative funding |
|---|---|---|
| Tractive | GPS, activity, sleep, behavior and vital-sign tracking for dogs and cats | About $38 million |
| Fi | GPS, activity, sleep and AI behavior tracking, including satellite connectivity | About $40 million |
| Invoxia | GPS, activity, sleep, heart rate, respiratory rate and heart-rate variability | Precise total not publicly disclosed |
| PetPace | Clinical monitoring of vital signs, behavior, pain-related patterns and location | Previously described as below $10 million; exact total uncertain |
| Petcube | GPS, activity monitoring and veterinary chat within a broader pet-device platform | About $13.8 million |
| Maven Pet | Health-first tracking of heart rate, respiratory rate, activity, sleep and behavior | About $3 million |
| FitBark | GPS, activity, sleep and behavior tracking, with strong research use | About $125,000 publicly recorded |
Is there already a clear leader in pet health trackers?
Tractive is clearly ahead in pet health trackers today, with Fi as the strongest consumer challenger and PetPace and Invoxia leading narrower medical niches.
The gap is larger than the number of competing brands suggests. Tractive reported more than 1.4 million active users after absorbing Whistle and has sold trackers across more than 175 countries. It had already passed €100 million in annual recurring subscription revenue before hardware sales.
No independent competitor has published a similar combination of paying users, recurring revenue and international reach. Fi has a strong brand and a growing product range, but it does not disclose subscriber or revenue figures that place it close to Tractive. Invoxia reports more than 400,000 users across its entire tracking business, although that figure also includes vehicles, bicycles and valuables.
The smaller health specialists lead where Tractive remains less advanced. PetPace monitors a wider set of clinically useful measurements and gives veterinarians their own dashboard. Invoxia has built one of the category's best real-world cardiac datasets. Maven has added peer-reviewed evidence to a relatively accessible consumer subscription.
The market shape is pretty clear. Tractive leads the overall category by a wide margin. Fi is the most credible independent consumer rival. PetPace is the health-monitoring specialist, while Invoxia and Maven are the smaller companies most likely to challenge it.
If you want more recent data on this point, please see our latest Pet Tech market report.
This market map, featured in our Pet Tech market deck, highlights top companies and startups in the pet tech market
Which pet health tracker has built the biggest real business?
Tractive has built by far the biggest pet health tracker business, with more than €100 million in annual recurring subscription revenue before counting device sales.
That revenue level changes the comparison. Tractive is already operating a large subscription company, while most rivals still reveal their progress through product launches, reviews, partnerships or research projects.
The company has also said it remained cash-flow positive through nearly all of its history. That is unusual in connected hardware, where companies have to subsidize devices, pay cellular fees, replace faulty units and keep improving an app long after the original purchase.
Tractive's reported revenue and user numbers also fit together reasonably well. Dividing €100 million in recurring revenue by 1.4 million active users gives roughly €71 per user annually. The dates and definitions do not align perfectly, so this is only a rough check. Still, the result sits within the range of Tractive's subscription pricing and suggests the figures describe a real, functioning customer base.
Fi says its products are trusted by millions of pet parents and has accumulated tens of thousands of customer reviews. Those figures show broad awareness, but they do not reveal how many subscriptions remain active or how much revenue Fi earns. Petcube has an established camera and pet-services business, although it does not separate tracker revenue. Maven's hundreds of reviews show early commercial demand, while PetPace and FitBark disclose very little about active paid users.
Tractive can now finance software, support, connectivity and new devices from its own customer base. Its smaller rivals still have to protect cash, charge premium prices or stay focused on a narrower group of owners.
Is Fi actually close to catching Tractive in pet health trackers?
Fi still trails Tractive by a wide margin on proven scale, even though Fi currently leads on battery design and remote-location tracking.
Fi's regular Series 3+ collar can last up to three months under favorable conditions. The hardware is built directly into the collar, which feels cleaner and more durable than attaching a separate tracker to a normal collar. Fi also monitors barking, licking, scratching, eating, drinking, sleep and activity.
The Fi Mini has expanded the brand beyond larger dogs. It is designed for small dogs, puppies and cats, giving Fi a much broader addressable market than it had a few years ago.
Fi's most distinctive product is the Ultra. It combines normal GPS and cellular tracking with T-Mobile's Starlink-powered direct-to-cell service. During testing by The Verge, the tracker successfully sent locations from an area with no normal LTE reception.
That makes Fi the strongest option for dogs travelling through remote parts of the United States. The limitation is battery life. Fi's regular products can run for weeks or months, while the Ultra generally lasts only one or two days because it uses several radios and checks location much more often.
Fi has created a useful premium product, especially for hikers, hunters and owners living near cellular dead zones. It has not produced public commercial figures suggesting that the wider company is close to Tractive.
Tractive still has the larger dog and cat range, the broader international operation and a far more visible subscription business. Fi can narrow the gap through better hardware, but it still has to prove that those products are creating comparable customer scale.
If you want more recent data on this point, please see our latest Pet Tech market report.
As this chart shows, and as featured in our Pet Tech market deck, search interest in pet cameras has risen sharply
Which pet health tracker monitors the most meaningful health data?
PetPace is currently the strongest pure health tracker, while Tractive covers the widest mix of pets and everyday tracking needs.
PetPace continuously follows temperature, pulse, respiratory rate, heart-rate variability, activity, sleep, body position and behavioral patterns linked with pain or stress. Veterinarians can review the same information through a clinical dashboard and use it for recovery, chronic disease or senior-pet monitoring.
That clinical connection gives PetPace more depth than a normal consumer tracker. The system is built for situations where a change in breathing, posture or resting heart rate could affect a medical decision.
Invoxia provides the strongest consumer alternative for cardiac monitoring. Its Biotracker estimates heart rate and respiratory rate from collar movement and now adds heart-rate variability. Invoxia uses those measurements to identify changes in stress, recovery and possible discomfort.
Maven occupies a simpler middle ground. It tracks heart rate, resting respiratory rate, activity, sleep, itching and drinking behavior, then compares each animal with its own normal baseline. It lacks GPS, which makes it less useful for escape prevention but keeps it focused on health.
Tractive now measures resting heart and respiratory rates on compatible trackers. It also monitors activity, sleep, barking, scratching and roaming. Its advantage is breadth: the company supports both dogs and cats and combines health changes with live location and escape alerts.
Fi tracks more visible behaviors than most competitors, including licking, barking, scratching, eating and drinking. Those features can help owners notice a problem, although Fi currently provides less physiological detail than PetPace or Invoxia.
For owners with a sick, elderly or recovering pet, PetPace offers the deepest monitoring. Tractive is the stronger everyday product for households wanting location, wellness and health changes in one place. Invoxia and Maven are more focused choices for owners who care about biometrics but do not need a full clinical system.
Which pet health tracker has the strongest clinical evidence?
PetPace has the broadest clinical evidence in pet health trackers, while Invoxia has completed the strongest large real-world biometric study.
PetPace has appeared in peer-reviewed research covering activity measurement, osteoarthritis pain, body position and physiological monitoring. Researchers have compared its activity data with validated monitors and tested whether its measurements can help distinguish healthy dogs from dogs experiencing pain.
The studies do not prove that every PetPace alert is medically accurate. They do show that independent veterinary researchers have used the system repeatedly across different clinical questions.
Invoxia's AI-COLLAR study followed 703 dogs from 113 breeds in 29 countries, with a median monitoring period of 189 days. The researchers used the data to build reference ranges for resting heart rate and respiratory rate across different ages, body sizes, health conditions and times of day.
That sample is far larger and longer than most pet-wearable studies, which often follow a few dozen animals for a short period. Invoxia employees were among the authors, so the research was commercially connected, but it still went through peer review and produced a valuable dataset.
Maven has also moved beyond company claims. A prospective study compared its resting-respiratory-rate measurements with manual counts and was published through the American Veterinary Medical Association. The results supported Maven's use for home respiratory monitoring, although the initial research focused mainly on apparently healthy dogs.
FitBark remains widely used for activity research. More than 150 research institutions and veterinary schools have reportedly used the device in studies involving mobility, osteoarthritis, rehabilitation, nutrition, sleep, skin problems and anxiety. Its measurements are narrower than those offered by PetPace or Invoxia, but researchers know the platform well.
Tractive may have the largest volume of real-world pet data, yet the company has published less independent validation for its newer heart and respiratory features. Fi also has a large consumer product and detailed behavioral monitoring, but its public clinical evidence remains limited.
| Startup | Strongest research evidence | What we can reasonably conclude |
|---|---|---|
| PetPace | Multiple published studies across activity, pain, posture and vital signs | Broadest clinical research base |
| Invoxia | International long-term study of 703 dogs | Strongest large biometric dataset |
| Maven Pet | Peer-reviewed comparison of collar and manual respiratory measurements | Most credible emerging health-first challenger |
| FitBark | Use by more than 150 research institutions and veterinary schools | Strong research utility for activity and behavior |
| Tractive | Very large consumer dataset but limited independent validation of newer vital-sign features | Strong data scale, weaker public clinical proof |
| Fi | Detailed behavioral monitoring with little published clinical validation | Strong consumer product, limited medical evidence |
If you want more recent data on this point, please see our latest Pet Tech market report.
This chart, included in our Pet Tech market deck, shows annual VC investment in pet tech startups
Which pet health tracker is best at finding a lost pet?
Tractive is the best all-round lost-pet tracker today, while Fi Ultra is better for remote US areas without normal cellular coverage.
Tractive combines live GPS, virtual fences, escape notifications, location history and Wi-Fi power-saving zones. Its trackers work across more than 175 countries, and the company has years of experience dealing with different mobile networks, battery conditions and pet-owner alerts.
The company's large installed base also reduces the risk of buying an experimental product that could lose support. Lost-pet tracking depends heavily on app reliability, billing, replacement hardware and customer service, not only the accuracy of the GPS chip.
Fi has a clear advantage when a dog leaves cellular coverage. The Ultra can connect through T-Mobile's direct-to-cell satellite service using Starlink, allowing it to send a location from places where a standard LTE tracker becomes unreachable.
The trade-off is charging. Fi Ultra generally lasts one or two days, compared with much longer battery life from the normal Fi Series 3+ and several competing trackers. Owners need to remember to charge it before a remote trip.
Invoxia's latest Biotracker also improves the lost-pet experience with one-second updates in live mode and LTE-M connectivity. Petcube offers a dedicated lost-dog mode and relatively inexpensive service. FitBark supports multiple LTE networks and stores several years of location history.
For normal daily use, Tractive remains the safer choice because it combines proven international coverage, mature software and reasonable battery life. Fi Ultra is better for hiking, hunting or living in areas where cellular coverage regularly disappears.
Which pet health tracker gives owners the best value?
Tractive gives most owners the best value today, while Invoxia is the strongest subscription-free health option and Maven works well for multi-pet homes monitoring chronic conditions.
Tractive's hardware usually costs less than $100, and its annual cost falls when owners commit to a longer plan. That gives customers live location, virtual fences, activity, sleep, behavioral changes and some vital-sign monitoring within one established app.
Invoxia uses a more flexible pricing model. Owners can access basic Bluetooth health tracking without paying for an ongoing subscription. They can then add a paid health-analysis plan or a GPS plan when they need deeper monitoring or cellular location.
That unbundling is useful. Someone monitoring an elderly dog's breathing at home should not have to pay forever for mobile data that the tracker rarely uses.
Maven costs roughly $168 per year on its annual plan and can cover as many as three pets. The price looks high beside a basic activity tracker, but it becomes much more reasonable for a household with several older animals.
Fi's standard annual membership costs about $189. Owners are paying for long battery life, polished integrated collars and detailed behavior monitoring. Fi offers real advantages, although many ordinary households can get the essential safety features for less through Tractive.
PetPace sits at the premium end because it combines advanced sensors, cellular service, telemedicine and veterinarian access. The cost makes sense for a dog with heart disease, chronic pain or a complicated recovery. A healthy young pet is unlikely to need that level of monitoring.
FitBark and Petcube remain cheaper alternatives for owners mainly interested in GPS and activity. Their health features are lighter, so the lower price comes with a narrower view of the animal.
This chart, included in our Pet Tech market deck, looks at Tractive’s strategy in pet tech
Which pet health tracker has the strongest business model and support operation?
Tractive has the strongest pet health tracker business model and the only support operation already proven at large international scale.
Connected pet hardware creates ongoing costs long after the tracker leaves the factory. The company still has to pay for mobile data, maintain the app, replace broken devices, answer support requests and improve location accuracy.
Tractive funds that work through recurring subscriptions spread across a large customer base. It can keep the device price relatively accessible, then offer annual or multiyear plans that collect predictable revenue.
As seen above, the network already spans more than 175 countries. Tractive has also shown that it can handle a large customer migration after buying Whistle. Former Whistle users received replacement devices and had remaining subscription time transferred to the new platform.
Fi follows a similar subscription model with higher annual pricing. That can produce more revenue per customer, but it also raises expectations. Fi needs its better battery life, industrial design and AI features to feel clearly superior every year.
Maven and PetPace can survive with fewer customers because their products address more expensive health problems. An owner may readily pay a premium when monitoring heart disease or post-operative recovery. Their challenge is reaching those owners at the right moment, often through veterinarians.
Invoxia benefits from using some of the same tracking technology across pets, vehicles, bicycles and valuables. That spreads engineering costs across several categories. Petcube has a comparable advantage through its cameras, veterinary chat and existing pet-owner accounts.
Tractive remains ahead because the model has already worked in practice. Its subscription base supports the service operation, while the acquisition by Bending Spoons gives it additional capital and consumer-software expertise.
What pet health tracker advantage is hardest for competitors to copy?
Tractive's installed data network is the hardest overall advantage to copy, while PetPace and Invoxia have stronger defenses inside medical monitoring.
Most competitors can buy similar GPS modules, accelerometers, batteries and LTE chips. They can also add virtual fences, activity goals and sleep charts without inventing new hardware.
Tractive has years of location, movement, sleep and health-pattern data from a very large population of dogs and cats. That history can improve battery management, personalized baselines, escape detection and comparisons between similar animals.
The company can compare one pet with animals of a similar breed, age, weight and lifestyle. Those comparison groups become more useful as the dataset grows, giving Tractive an advantage that a new tracker cannot reproduce during its first few years.
PetPace has built a different kind of protection through veterinary workflows. Clinics can review patient trends, alerts and recovery information inside a dedicated portal. Once a veterinarian has used the same system across many cases, switching to another collar becomes more disruptive.
Invoxia's advantage comes from signal processing and cardiac data. Turning small collar movements into useful estimates of heart rate, breathing and heart-rate variability requires more than a standard activity algorithm. Its long-term study of 703 dogs gives the company reference data that smaller entrants do not have.
Maven is beginning to build its own personalized baselines and veterinary summaries, although its dataset is still smaller. Fi has an important design advantage and early access to satellite pet tracking. The satellite network belongs to T-Mobile and Starlink, however, so other tracker companies may eventually use similar connectivity.
If you want more recent data on this point, please see our latest Pet Tech market report.
This chart, included in our Pet Tech market deck, shows annual funding in pet tech startups
Which pet health tracker startup has the most momentum right now?
Fi currently has the strongest product momentum among independent pet health tracker startups, while Tractive has the strongest strategic momentum.
Fi has moved from one core dog collar toward a much broader range. The Series 3+ serves mainstream dog owners, the Mini covers small dogs and cats, and the Ultra targets owners travelling beyond cellular coverage.
Each product addresses a different weakness in Fi's earlier range. The Mini makes the brand relevant to more animals. The Ultra gives Fi a feature that competitors cannot yet match in the United States. The normal Series 3+ keeps the company's long-battery-life advantage.
The Ultra's short battery life stops it from becoming the default product for every owner. Even so, it gives Fi a strong position in remote tracking and makes the brand easier to distinguish from cheaper GPS collars.
Tractive's recent moves carry more business weight. It bought Whistle, moved the customer base onto its own platform and then became part of Bending Spoons. The new owner has said it plans to invest in health features, safety, devices and international growth.
Invoxia is showing the strongest technical momentum among the smaller health specialists. Its latest Biotracker adds heart-rate variability, faster live GPS and a health mode that works without a mandatory subscription.
Maven has improved its credibility through peer-reviewed respiratory research. PetPace has added GPS, cellular service and telemedicine to its newer collar. Both companies are moving forward, although neither has reported the kind of adoption jump that would change the overall ranking yet.
Could Life360 overtake pet health tracker startups?
Life360 is the most credible outside threat to pet tracker startups because it can place pet tracking inside an app already used by more than 97 million people.
Life360 Pet GPS adds live location, safe-zone alerts and pet-recovery features to the same map people use for family members, vehicles and Tile devices. Customers on higher membership tiers can add pet tracking without starting a completely separate digital relationship.
That distribution gives Life360 a shortcut. Converting only 1% of its reported user population into pet-tracker customers would approach one million devices. This is not a forecast because many users belong to the same household, and the pet product is still geographically limited. It does show how quickly an established platform could become large.
Life360 currently focuses on location and recovery. Its product does not offer the same depth in heart rate, respiratory rate, pain, recovery or veterinary monitoring as PetPace, Invoxia or Maven.
The company therefore threatens Tractive, Fi, Petcube and FitBark first. Those brands all rely heavily on the value of knowing where a pet is and receiving an alert when it leaves a safe area.
A veterinary chain, insurer or large pet company could also enter through an acquisition. PetPace or Maven could give a buyer a ready-made health platform, while Invoxia could bring more advanced cardiac sensing.
For now, Life360 has the strongest distribution threat, but Tractive still has a more complete pet-specific product and far deeper experience with pet behavior, hardware and subscriptions.
This chart, included in our Pet Tech market deck, compares the main business model options for pet GPS wearable companies
Which pet health tracker startups are actually ahead?
Tractive is the clear overall leader in pet health trackers today, with Fi in second place and PetPace leading the medical side of the category.
Tractive's more than 1.4 million active users and over €100 million in recurring subscription revenue put it far ahead of every independent rival on proven commercial scale. It also covers dogs and cats, operates internationally and combines location, activity, sleep, behavior and vital-sign monitoring.
Fi ranks second because it is the strongest independent consumer company. It has raised around $40 million, built some of the category's best hardware and now leads in satellite-enabled pet tracking. Its main weakness is the lack of disclosed subscriber or revenue figures comparable with Tractive.
PetPace ranks third overall and first for clinical monitoring. It measures the widest set of physiological signals, connects directly with veterinarians and has the broadest medical research base. Premium pricing and a smaller disclosed customer footprint keep it below Fi in the overall market.
Invoxia ranks fourth because its cardiac sensing, heart-rate variability and large long-term dog study give it a real technical edge. It could move higher if those advantages start producing a much larger pet-specific customer base.
Maven ranks fifth as the most credible emerging health-first challenger. Its peer-reviewed respiratory monitoring and multi-pet subscription give it a clear position, although the business is still young.
Petcube ranks sixth because its cameras, veterinary chat and existing customer base make it a credible low-cost platform. Its tracker still lacks the health depth of the companies above it.
FitBark ranks seventh. It remains respected in veterinary research and offers affordable GPS and activity tracking, but its commercial scale and product development have fallen behind the leading group.
The ranking could change if pet wearables become a standard part of veterinary care or insurance. That would increase the value of PetPace, Invoxia and Maven. If the market remains centered on escape prevention, location and general wellness, Tractive and Fi should stay in front.
| Rank | Startup | Why it currently holds this position |
|---|---|---|
| 1 | Tractive | Clear leader in active users, recurring revenue, international reach and overall product breadth |
| 2 | Fi | Strongest independent consumer challenger, with leading battery design, behavior tracking and satellite connectivity |
| 3 | PetPace | Best medical-monitoring platform, supported by advanced vital signs, veterinary workflows and clinical research |
| 4 | Invoxia | Strongest biometric innovator, especially in cardiac and respiratory monitoring |
| 5 | Maven Pet | Most credible emerging health-first challenger, with peer-reviewed evidence and practical multi-pet pricing |
| 6 | Petcube | Affordable GPS platform supported by cameras, veterinary chat and an existing pet-owner ecosystem |
| 7 | FitBark | Established research and activity tracker that now trails the leaders in commercial and technical momentum |
If you want more recent data on this point, please see our latest Pet Tech market report.
OUR METHODOLOGY
This analysis compares the pet health tracker companies that currently sell an active wearable and monitor at least one health or behavioral metric. We include GPS-first trackers that have added wellness features and health-first collars built around vital signs, recovery or veterinary monitoring.
We compare the companies across commercial scale, product breadth, health-monitoring depth, clinical evidence, lost-pet performance, customer value, business-model durability, defensibility and recent momentum. The overall ranking comes from the full comparison rather than one product feature or a mechanical score.
Disclosed recurring revenue, active users, international coverage, independently published research and demonstrated product performance carry more weight than broad marketing claims, review totals or company-wide user figures that cannot be tied directly to pet tracking.
We keep commercial leadership separate from medical leadership. Tractive and Fi are judged mainly as consumer subscription businesses, while PetPace, Invoxia and Maven receive more weight for physiological measurements, veterinary workflows and published validation.
Tractive remains in the ranking after its acquisition by Bending Spoons because it still defines the competitive benchmark. Whistle is excluded as a separate company because Tractive acquired the business and closed the standalone platform. Life360 is treated as an outside threat rather than a startup competitor.
Funding figures are presented cautiously because public records are incomplete and databases may count equity, debt, grants and extensions differently. We use rounded disclosed totals where possible and avoid treating uncertain amounts as exact.
Key sources used for this analysis include Tractive on the Whistle acquisition, active users and global reach, Tractive on the completed Bending Spoons acquisition, Tractive's supported-country documentation, Fi's product comparison, Fi on the Ultra and direct-to-cell satellite connectivity, The Verge's independent Fi Ultra test, Invoxia's Biotracker documentation, PetPace's veterinary platform, PetPace's research resources, the Maven respiratory-rate study, FitBark's research adoption information, and Life360's pet tracker launch.
This chart, featured in our Pet Tech market deck, illustrates revenue distribution by customer segment in the pet tech market
Related blog posts
- Modern vet clinics: which startup is ahead?
